On January 23, 2024, Glycotest, Inc. closed the transaction. The company has raised $0.75 million in second and final tranche for aggregate gross proceeds of $1 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63 GBX | 0.00% | 0.00% | +5.00% |
Apr. 15 | Netscientific's ProAxsis Secures Investment for Product Development | MT |
Apr. 15 | NetScientific investee secures funding to develop product range | AN |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
63 GBX | 0.00% | 0.00% | 18.79M | ||
23.19 CNY | +1.35% | +3.02% | 7.65B | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.00% | 18.79M | |
+31.41% | 12.02B | |
+14.40% | 3.06B | |
+2.96% | 1.42B | |
-8.46% | 1.22B | |
+1.15% | 616M | |
-10.84% | 579M | |
+35.79% | 577M | |
-4.17% | 492M | |
+33.85% | 488M |
- Stock Market
- Equities
- NSCI Stock
- News NetScientific plc
- Glycotest, Inc. announced that it has received $1 million in funding from EMV Capital Ltd, NetScientific plc, Shanghai Fosun Pharmaceutical Co., Ltd.